Narcolepsy Trials
Brilliance 302/304 (Narcolepsy Type 1)
Brilliance 303 (Narcolepsy Type 2)
Struggling with excessive daytime sleepiness or sudden sleep attacks?
The Brilliance study is evaluating an investigational medication for adults living with narcolepsy, a neurological sleep disorder that can cause:
Overwhelming daytime sleepiness
Sudden sleep episodes
Difficulty staying alert during daily activities
Researchers are studying whether this treatment may help:
Improve wakefulness during the day
Reduce unplanned sleep episodes
Support better daily functioning and quality of life
You may qualify if you:
Have been diagnosed with narcolepsy type 1 or type 2
Experience excessive daytime sleepiness
Are looking for additional treatment options
What participation involves:
Study medication (oral or other form depending on protocol)
Sleep assessments and symptom tracking
Regular visits with a clinical research team
Participants receive:
Study-related care at no cost
Close monitoring by sleep specialists
Compensation for your time
Interested? Email us at research@tricoastalsleep.com or click here.
